Path-to-Market Strategy | #RxD
Who? Pharma's experts in path-to-market strategy, positioning and applied innovation.
What? IDEA Pharma is a Path-To-Market Strategy practice. Applied Design Thinking in early phase.
Where? Offices in UK & New York City, working with clients globally.
Why? Choosing a path to market successfully is a discipline, and like any discipline, it is best performed by specialists. Pharma works with IDEA to develop options for the 'best' path to market: clinically and commercially. IDEA supported the strategic direction and positioning for 8 out of the top 15 pharma product launches between 2015-2020. No other company comes close.
IDEA has been lucky enough to work with some of the best product teams in the industry, and we will only engage if we believe in the client team. It's a philosophy that has ensured we love what we do, and that we can make the kind of difference that matters,.
How? Areas of industry leadership include:
• Strategic Positioning
• Portfolio/ disease area Strategy
• Value Proposition
• Scenario planning, Strategy pressure test
• Communication Strategy
The path-to-market for a medicine is never obvious, so we develop design options: IDEAs that meet every hurdle: clinical, regulatory, and the important commercial hurdles (market access, reimbursement, competitor differentiation...). Clearing any one is relatively easy; clearing all of them is hard.
A thousand things can influence the trajectory of a product: choice of indication, patient population, patient profile, line of therapy, trial endpoints, and many more.
Products are the result of design decisions. When design is valued, great things happen.
Sign up to our IDEA Junkie Newsletter to get more insight into what we do and how we think: https://mailchi.mp/ideapharma.com/junkie-sign-up
Strategic marketing, disease area strategy, Scenario planning, differentiation, Communication strategy, Advisory meeting, IDEAtion, Path-to-medicine strategy, and Path to Market Strategy
Pharma Early Stage R&D, Path to Market and Positioning by the experts at IDEA Pharma
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 6 Apr 2024 | | |
Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 13 Apr 2024 | | |
MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 27 Aug 2020 | | |
Mahindra Group Executive Offices | Mahindra Group Executive Offices | Other 2 Nov 2020 | | |
MassChallenge Startup accelerator & VC, Venture Capital and Private Equity Principals | MassChallenge Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 15 Jan 2020 | | |
Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 12 Nov 2023 | | |
Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 8 Nov 2021 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 25 Nov 2022 31 Jan 2024 | | |
Alexion Pharmaceuticals, Inc. Pharmaceutical, Biotechnology, Biotechnology Research | Alexion Pharmaceuticals, Inc. Pharmaceutical, Biotechnology, Biotechnology Research | Not capitalistic Not partnership Event 11 Jan 2020 | | |
NHS England Insurance, Hospitals and Health Care | NHS England Insurance, Hospitals and Health Care | Other 2 Oct 2019 | |